Analyst Ratings for NxStage Medical (NXTM)
NXTM Rating Summary
NXTM Price Target Summary
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$20.78 (+42.9%)
Avg. $ Target:
$20.78 (+42.9%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/4/2012 | Northland Securities | Downgrade | Market Perform (Outperform) |
12.00 (18.00) |
12.14 | 14.54 | 19.77% | Details |
| 10/10/2012 | Wells Fargo | Upgrade | Market Perform (Underperform) |
12.50 (N/A) |
12.68 | 14.54 | 14.67% | Details |
| 7/20/2012 | ThinkEquity | New Coverage | Buy (N/A) |
22.00 (N/A) |
15.27 | 14.54 | -4.78% | Details |
| 2/28/2012 | Feltl & Co | Downgrade | Hold (N/A) |
22.00 (N/A) |
20.87 | 14.54 | -30.33% | Details |
| 11/17/2011 | Piper Jaffray | New Coverage | Overweight (N/A) |
24.00 (N/A) |
19.59 | 14.54 | -25.78% | Details |
| 8/4/2011 | Rodman & Renshaw | Upgrade | Market Perform (N/A) |
N/A (N/A) |
19.27 | 14.54 | -24.55% | Details |
| 6/10/2011 | JPMorgan | Upgrade | Overweight (N/A) |
N/A (N/A) |
17.85 | 14.54 | -18.54% | Details |
| 5/2/2011 | Stephens | New Coverage | Overweight (N/A) |
N/A (N/A) |
24.50 | 14.54 | -40.65% | Details |
| 3/16/2011 | WJB Capital | New Coverage | Buy (N/A) |
N/A (N/A) |
19.70 | 14.54 | -26.19% | Details |
| 12/17/2010 | Lazard Capital | New Coverage | Buy (N/A) |
N/A (N/A) |
23.37 | 14.54 | -37.78% | Details |
| 12/3/2010 | Jefferies » Updated 11/9/2012 |
New Coverage | Buy (N/A) |
16.00 (21.00) |
22.66 | 14.54 | -35.83% | Details |
| 10/8/2010 | Leerink Swann » Updated 6/18/2012 |
New Coverage | Outperform (N/A) |
25.00 (N/A) |
20.37 | 14.54 | -28.62% | Details |
